This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
RFA-AI-14-055: Centers for Medical Countermeasures against Radiation Consortium (U19) - Receipt date Oct. 3, 2014
RFP-NIAID-DAIT-NIHAI2014005: Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services. Response Date – Dec. 1, 2014
HHS, NIH and CDC Small Business Innovative Research (SBIR) Program Solicitation PHS 2015-1 (PDF). Topic #338: Predictive Biomarkers of Adverse Reactions to Radiation Treatment; Topic#339: Systemic Targeted Radionuclide Therapy. Closing Date Nov. 5, 2014.
FDA draft guidance (2014), Product Development Under the Animal Rule (PDF)
BAA-13-100-SOL-00013: Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures for BARDA. Posted July 31, 2013
Department of Defense: Peer Reviewed Medical Research Program (PRMRP)—Addresses numerous research topic areas including illnesses associated with radiation exposure. Pre-proposals due late June/July, 2014.
Department of Defense: Peer Reviewed Cancer Research Program (PRCRP)—Addresses numerous cancer research topics including cancers associated with radiation exposure. Pre-proposals due June 10, 2014.
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated September 17, 2014